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ABSTRACT 
Graphene has the potential to make a very significant impact on society, with important 
applications in the biomedical field. The possibility to engineer graphene-based medical devices 
at the neuronal interface is of particular interest, making it imperative to determine the 
biocompatibility of graphene materials with neuronal cells. Here we conducted a comprehensive 
analysis of the effects of chronic and acute exposure of rat primary cortical neurons to few-layers 
pristine graphene (GR) and monolayer graphene oxide (GO) flakes. By combining a range of cell 
biology, microscopy, electrophysiology and “omics” approaches we characterized the graphene-
neuron interaction from the first steps of membrane contact and internalization to the long-term 
effects on cell viability, synaptic transmission and cell metabolism. GR/GO flakes are found in 
contact with the neuronal membrane, free in the cytoplasm and internalized through the endo-
lysosomal pathway, with no significant impact on neuron viability. However, GO exposure 
selectively caused the inhibition of excitatory transmission, paralleled by a reduction in the 
number of excitatory synaptic contacts, and a concomitant enhancement of the inhibitory 
activity. This was accompanied by induction of autophagy, altered Ca2+ dynamics and by a 
downregulation of some of the main players in the regulation of Ca2+ homeostasis in both 
excitatory and inhibitory neurons. Our results show that, although graphene exposure does not 
impact on neuron viability, it does nevertheless have important effects on neuronal transmission 
and network functionality, thus warranting caution when planning to employ this material for 
neuro-biological applications. 
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Graphene is a carbon crystal consisting of a two-dimensional crystalline honeycomb-lattice 
structure made of sp2-hybridized carbon atoms.1, 2 Because of its two-dimensional shape and 
interesting electrical and mechanical properties1, 3, 4 graphene is considered one of the most 
promising nanomaterials for biomedical applications and it is already employed in many 
industrial sectors such as optics, electronics and mechanics.1, 3, 5-7 The development of large-scale 
synthesis procedures and the increasingly common use of graphene products lead to the critical 
question of nanosafety. Indeed manufactures, consumers and eventually patients are all 
potentially exposed to various extent to different graphene-based materials. A number of recent 
reports have described the toxicity of graphene and graphene-based materials in both in vitro and 
in vivo systems8-13, nevertheless leaving the debate on graphene biocompatibility still open. The 
inconsistence among the various studies could be due to the different graphene materials used, 
such as monolayer or few layer graphene, graphene oxide, reduced graphene oxide and 
functionalized graphene.2 Biocompatibility in fact depends not only on the in vitro / in vivo 
system adopted, but also on the physicochemical characteristics of the materials including their 
dimensions, shape and functionalization.6, 14, 15 The intrinsic characteristics of graphene, especially 
its transparency, flexibility and high conductivity make this material particularly attractive for 
neuroscience applications, as it represents a promising tool for neuronal implants and bio-devices 
for neuro-oncology and neuro-regeneration research.16, 17 Recently, healthy primary neurons were 
reported to grow and form synaptic connections on planar casted graphene-based substrates.18 
However, no data are as yet available on the potential physiological and pathological effects of 
the short- and long-term environmental exposure of primary neurons to pristine graphene (GR) 
and graphene oxide (GO) nanosheets. 
 
On the basis of these considerations, we tested the biocompatibility of GR and GO flakes with 
neuronal cells. Parameters such as viability, morphology and functionality of in vitro networks of 
primary cortical neurons, as well as the intracellular route of internalized flakes, were first 
studied by employing a range of cell biology techniques, confocal microscopy, transmission and 
scanning electron microscopy, as well as patch-clamp electrophysiology. To understand in more 
detail the neurophysiological changes induced by flake exposure we investigated the protein and 
lipid contents of cells exposed to graphene by undertaking proteomics and metabolomics 
approaches. We found that both acute and chronic exposure to both GR and GO nanosheets do 
not affect cell viability, excitability and network formation. However, chronic GO exposure 
induced marked effects on neuronal network activity including a marked down-regulation of 
excitatory transmission accompanied by a decreased density of excitatory synaptic contacts, an 
opposite upregulation of inhibitory transmission and a strongly upregulated autophagic reaction. 
These effects were accompanied by alterations in the expression of membrane phospholipids and 
in a multiplicity of molecules involved in Ca2+ homeostasis and dynamics including 
calcitriol/vitamin D and several Ca2+-binding proteins that can account for the physiological 
effects of GO on neuronal network activity. As GO is the most largely employed graphene 
derivative for technological applications and the most biologically reactive, our results suggest 
caution in the use of this material for neurobiological applications.  
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RESULTS  
Synthesis and characterization of pristine graphene and graphene oxide 
The graphene-related materials used in the present study were few-layer GR and monolayer 
GO flakes. GR flakes were prepared by exfoliation of graphite through interaction with 
melamine by ball-milling treatment.19 After exfoliation, melamine could be easily removed by 
filtration to obtain stable dispersions of few-layer graphene. Elemental analysis was performed 
in order to check any possible melamine traces into the final GR dispersion. Since 0.09 ppm 
melamine was found in dispersions of 0.09 mg/ml GR, melamine was included as internal 
control in all the experiments involving GR flakes (0.09 ppm melamine in H2O). Monolayer GO 
was provided by the Grupo Antolin Ingeniería (Burgos, Spain) by oxidation of carbon fibers 
(GANF Helical-Ribbon Carbon Nanofibres, GANF®). Initial GO suspensions were washed with 
water to remove the presence of acids and were fully characterized. The elemental analysis gave 
the following results (as percent weight): 47.71 ± 0.03 wt %C, 3.04 ± 0.02 wt %H, 0.15 ± 0.01 
wt %N and 0.27 ± 0.03 wt %S. Oxygen content was therefore calculated at ca. 48% by weight. 
Zeta-potential values were around -35 mV at physiological pH (data not shown). Dynamic light 
scattering (DLS) and transmission electron microscopy (TEM) analysis revealed a higher lateral 
size distribution of GR (500-2000 nm) compared to GO (100-1500 nm) flakes (Figure S1a-b). 
Raman spectroscopy provided a further characterization of the two materials. Graphene exhibits 
G and 2D modes around 1573 and 2700 cm-1, that always satisfy the Raman selection rules while 
the D peak around 1345 cm-1 required a defect for its activation (Figure S1c). The intensity 
ratio between the D and the G band was calculated at different locations and used to quantify 
defects on the graphene surface, giving a significant low value for GR (0.22 ± 0.05; n=5) 
compared to GO (0.81 ± 0.05; n=5). Thermo-gravimetric analysis (TGA) was also used to 
quantify the degree of functionalization of graphene-related materials (Figure S1d). The low 
weight loss observed in GR (7%) corroborated the low quantity of oxygen groups generated by 
the exfoliation process in comparison to the values obtained for GO (46%). A detailed 
description of material production is available in the Methods section. 
 
Exposure to GR and GO nanosheets does not affect viability of primary cortical 
neurons 
We tested GR and GO on primary neurons isolated from embryonic brain cortices and cultured 
for up to 17 days in vitro (DIV). Cultures were incubated at 3 DIV with GR and GO at 1 and 10 
µg/ml. Immunohistochemistry and fluorescence microscopy were used to evaluate GR and GO 
toxicity after 24 h, 96 h and 14 days of incubation to assess the effects of short- and long-term 
graphene exposure. Control groups were non-treated cells, cell treated with an equal volume of 
either 0.09 ppm melamine/H2O (“Ctrl” for GR samples) or H2O (“Ctrl” for GO samples) (Figure 
1a-d). Propidium iodide (PI) and fluorescein diacetate (FDA) were used to detect dead and 
living cells, respectively. Samples were then imaged using an upright epifluorescence 
microscope and PI- and FDA-positive cells were quantified by imaging software analysis 
(Figures S2-S4). To evaluate network development, parallel samples were processed for 
confocal fluorescence microscopy using antibodies specific for the neuronal cytoskeleton (anti β-
III tubulin) and Hoechst staining to visualize nuclei (Figure 1b,d, right panels). GR and GO 
flakes were visualized by reflected light imaging acquisition modality.20 The results of this 
analysis clearly indicate that exposure to either GR or GO flakes did not affect cell survival or 
network development at any of the concentrations and exposure times tested. As a further 
viability test, electrophysiological analysis of resting membrane potential by patch-clamping (see 
below; Table S1), a very sensitive index of neuronal health, confirmed that the GR/GO 
treatments for up to 14 days do not have any detrimental effect on primary neurons. 
To investigate the physical interaction of GR and GO flakes with neuronal cells, electron 
microscopy analysis was used. GR and GO flakes were identified by their characteristic 
laminated shape, high electron dense structure and typical reflected bright shadow in their 
proximity.11, 21 Scanning electron microscopy (SEM) allowed us to explore the distribution of 
flakes in the cellular network and their interaction with the cell membrane (Figure 1e-h). 
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Cortical neurons were exposed to GR and GO flakes for 96 h and 14 days, then fixed and 
prepared for SEM analysis. Flakes could be seen adhering to the cell membrane (white 
arrowheads); however they did not seem to affect normal growth and development of the 
neuronal network, in accordance with the fluorescence microscopy data. It is important to note 
that most of the flakes in contact with the cell membrane were micro-sized flakes, suggesting 
that larger flakes are not taken up by cells and adopt a passive interaction behavior towards 
neurons.22 Nano-flakes were instead internalized, as shown by TEM analysis (Figure 1i-l). A 
higher amount of internalized flakes was found at later time points (14 days) compared to early 
times of incubation (96 h); however in all cases no internal damage and/or organelles disruption 
was noticed. The interaction of the nanosheets with the plasma membrane occasionally led to the 
formation of membrane invaginations (Figure S5); in other cases, rare events of flakes piercing 
through and mechanically disrupting the cell membrane were observed (Figure 1k).11, 21 As 
shown in Figure 1g-j, both GR and GO flakes (black arrowheads) were present inside cells as 
aggregate-like structures of various sizes and compactness. The aggregates were either freely 
localized in the cytosol (Figure 1l) or localized within membrane-bound vesicles (Figure 1i-
j), possibly belonging to the endo-lysosomal pathway. As discussed above, the non-homogenous 
flake dispersion in solution may explain the formation of aggregates, even though we cannot 
exclude that these agglomerates are formed inside cells, upon fusion of multiple vesicles to the 
same intracellular structures.  
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Figure 1. Cell death, cell viability and cell morphology of primary neurons 
exposed to GR and GO flakes. (a-d). Primary rat cortical neurons were exposed to GR (a, 
b) and GO (c, d) flakes (1 and 10 µg/ml) for 24 h, 96 h and 14 days, or to equivalent volumes of 
the respective vehicles (“Ctrl”, 0.09 ppm melamine / H2O for GR flakes, H2O for GO flakes). Cell 
death (a, c) and viability (b, d) were evaluated by fluorescence microscopy; neurons were 
stained with propidium iodide (PI) for cell death quantification, fluorescein diacetate (FDA) for 
cell viability and Hoechst 33342 for nuclei visualization. The percentages of PI- and FDA-
positive cells with respect to the total number of Hoechst-positive cells were calculated for each 
experimental group and normalized to the values of the untreated samples, set to 1 (red line). No 
statistically significant variations in cell death and cell viability were observed under all the 
experimental conditions (one-way ANOVA and Bonferroni’s post-hoc test, 3000 cells from n=3 
coverslips per experimental condition, from 3 independent neuronal preparations). In parallel 
samples, neurons were fixed and stained with anti-βIII tubulin antibodies (red channel) and 
Hoechst 33342 to visualize nuclei (blue channel), and then imaged by fluorescence confocal 
microscopy (b, d; right panels). GR/GO-flakes were acquired in the reflection light mode and are 
rendered in the green channel (scale bars, 20 µm). (e-h). SEM was used to study the interaction 
of flakes with neuronal cells. Neurons were exposed to GR and GO flakes for 24 h (not shown), 
96 h and 14 days, fixed and prepared for SEM analysis. A large number of flakes (white 
arrowheads) were found in contact with the cell membrane; however, cell morphology and 
network development were substantially unaffected. (i-l) The cell uptake of GR and GO and the 
intracellular localization of graphene nanosheets were studied by TEM. At 24 h, most of the 
flakes were found to be outside the cells (not shown). Starting from 96 h incubation flakes were 
internalized into intracellular vesicles (i , j ; black arrowheads), or free in the cytoplasm (l; black 
arrowheads). 
 
GR and GO nanosheets are internalized through the endo-lysosomal pathway 
To get more insights on the identity of the intracellular vesicles containing the flakes, the 
internalization and intracellular fate of GR and GO flakes were investigated by confocal 
fluorescence microscopy (Figure 2). When the percentage of neuronal cells that contacted 
graphene nanosheets was quantified by taking into account both internalized flakes and larger 
aggregates in contact with the cell membrane, the large majority of neurons were found to 
interact with GR/GO nanosheets (mean ± SEM: GR 75.5±1.7%; GO 74.5±3.9%). We then 
focused on the endo-lysosomal pathway, known to be the preferential destination of 
nanoparticles and nanomaterials.23-26 Neurons were fixed after 24 h, 72 h, 7 days and 14 days of 
GR and GO flakes exposure, and then marked with antibodies for early-endosomes (EEA1) and 
lysosomes (LAMP1). Three-dimensional Z-stack images were acquired by using a confocal 
laser-scanning microscope (CLSM). By adopting the reflection light acquisition modality20, the 
visualization of GR and GO flakes was possible also in confocal mode, allowing to precisely 
quantify the uptake of graphene nanosheets (Figure 2a, b, d, f,  h) and follow their 
intracellular location (Figure 2c, e, g). The evaluation of the percentages of co-localization 
between graphene and EEA1 or LAMP1 over the total amount of intracellular graphene revealed 
that GR and GO flakes are internalized with a time-dependent transition from EEA1-positive 
early endosomes (up to 72 h) to LAMP1-positive lysosomes, reaching a plateau value at 7 days 
(Figure 2), consistent with what found by other groups.24-27 However, it is important to stress 
(Figure 2a and Figure S5) that internalization regards a relatively small percentage of total 
graphene materials, while the majority of GR and GO flakes are not internalized, presumably 
because of their relatively big size22, 24, 28 and of the low phagocytic activity of neuronal cells.29 
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Figure 2. Intracellular trafficking of GR and GO nanosheets. Primary rat cortical 
neurons were exposed to GR and GO flakes (1 and 10 µg/ml) for 24 h, 72 h, 7 days and 14 days. 
Neurons were fixed and stained with anti-EEA1 and anti-LAMP1 antibodies for early endosome 
and lysosome identification, respectively, and with Hoechst 33342 for visualization of cell 
nuclei. Neurons were then imaged (b, d, f,  h) by confocal fluorescence microscopy and three-
dimensional images were acquired (scale bars, 20 µm in main images, 5 µm in zoomed images). 
(a) Total internal GR and GO flake internalization was quantified over time. (c, e) 
Quantification of the extent of co-localization of flakes with either EEA1- or LAMP1-positive 
organelles, analyzed using the JACOP plugin of the ImageJ software (white arrowheads; one-
way ANOVA and Bonferroni’s multiple comparison test, 50 cells from n=3 coverslips per 
experimental condition, from 3 independent neuronal preparations). (g) Comparison of the 
intracellular trafficking of GR and GO flakes shows a higher amount of GO flakes ending up in 
lysosomes, as a consequence of the higher internalization of GO as compared to GR flakes (a). 
 
Exposure to GR and GO nanosheets does not affect the intrinsic excitability of 
primary cortical neurons 
The intrinsic excitability of cortical neurons was assessed using single-cell patch-clamp 
recordings30-32 to measure the cell passive and active properties in the presence of either GR or GO 
flakes. The resting membrane potential and the input resistance recorded in neurons exposed to 1 
and 10 µg/ml of either GR or GO for 14 days were similar to untreated neurons or to vehicle-
treated neurons (Table S1). We then assessed whether the application of various concentrations 
of GR/GO nanosheets impacted on the intrinsic excitability of individual primary cortical 
neurons by recording action potential (AP) firing in response to 500 ms current injection of 
stepwise increasing amplitude by whole cell patch-clamp in the current-clamp configuration 
(Figure 3). The excitability of cortical neurons was virtually unaltered by exposure to either GR 
or GO and the firing rate vs injected current response curves of GR/GO treated neurons were not 
significantly different from those obtained from untreated neurons or vehicle-treated neurons 
(Figure 3). The analysis of the threshold and shape of the first elicited action potential also did 
not show any significant treatment-dependent difference in the current or voltage threshold, AP 
amplitude, width, rising slope or repolarizing slope (Table S1). Moreover, no differences in 
neuronal cell functionality were observed between low (1 µg/ml) and high (10 µg/ml) GR/GO 
flake concentrations. These results suggest that neither graphene form affects the correct 
maturation and expression of the passive and active membrane properties of primary neurons.  
To exclude that the lack of effect after 14 days exposure to graphene was due to graphene 
aggregation over time or to graphene internalization before complete cell maturation, the same 
experiments were performed on 14 DIV mature neurons acutely exposed to either GR or GO 
flakes for 24 h (Figure S6). Also under these conditions, no differences in the passive and 
active properties were found between treated and untreated neurons, confirming that graphene 
does not affect the basic electrophysiological properties of primary neurons, at least in the time 
window analyzed. We can also rule out the possibility that the preserved viability is attributable 
to the presence of astrocytes, as our cultures contain a very low and stable percentage of GFAP-
positive cells in the in vitro period investigated (mean ± SEM: Ctrl 6.5±0.9%; GR 6.8±0.7%; GO 
6.3±0.9%). 
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 Figure 3. Firing properties of primary cortical neurons upon chronic GR/GO 
flake exposure. Neuronal cells were incubated with either GR (a, c) or GO (b, d) flakes at 1 
µg/ml (a, b) and 10 µg/ml (c, d), or with the respective vehicles (Ctrl) for 14 days. 
Electrophysiological recordings were performed by whole cell patch-clamp in the current clamp 
configuration. The mean (± SEM) action potential frequency with respect to the injected current 
is shown. No significant differences were found between graphene-treated samples and untreated 
(N.T.) or vehicle-treated (Ctrl) neurons (one-way ANOVA, and Bonferroni’s post-hoc test, n=20 
cells per experimental condition, from 3 independent neuronal preparations). On the right of the 
plots, representative firing traces in response to current injections are reported. 
 
 
 
Exposure to GO but not GR decreases network activity and alters Ca 2+ dynamics 
in primary cortical neurons  
Given the substantial preservation of neuronal viability and excitability, we explored the 
presence of more subtle effects of graphene flakes on network activity, Ca2+ homeostasis and 
synaptic transmission. We quantitatively analyzed resting Ca2+ levels and spontaneous Ca2+ spikes 
in primary cortical neurons exposed to GR/GO flakes (10 µg/ml) using live imaging with 
ratiometric Fura-AM. Spontaneous Ca2+ transients reflect the firing of spontaneous action 
potentials by neurons present in these reverberating networks that are, in turn, the expression of 
the balance and interaction between excitatory and inhibitory synaptic transmission. It is also 
important to note that live imaging analyses predominantly investigate the activity of excitatory 
neurons that represent approximately 80% of the total neuronal population, as described 
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previously.33 Both control, GR- and GO-treated neurons displayed spontaneous Ca2+ transients 
(Figure 4a). However, the percentage of neurons showing rhythmic activity was significantly 
lower in GO-treated neurons (Figure 4b), as were the resting Ca2+ levels, which were decreased 
by GO treatment by approximately 50% with respect to vehicle-treated neurons (Figure 4c). 
Importantly, GO treatment significantly decreased the frequency of Ca2+ spikes both under basal 
conditions and under conditions of hyperexcitability induced by bicuculline, a specific antagonist 
of GABAA receptors34 (Figure 4d). Moreover, when the rise and decay of individual Ca2+ 
transients were analyzed, we found that Ca2+ transients in GO-treated neurons recovered faster 
than those in control neurons (Figure 4e-g). The same analysis, performed upon acute 
treatment of 14 DIV neurons with G and GO flakes for 24 h, did not reveal significant changes in 
any of the analyzed parameters (Figure S7a-d). Altogether, live Ca2+ imaging reveals a 
significantly decreased network activity and complex dysregulation of Ca2+ homeostasis.  
 
 
Figure 4. Ca 2+ dynamics in primary cortical neurons treated with GO for 14 days. 
(a) Representative spontaneous (left panels) or bicuculline-evoked (right panels) Ca2+-
oscillations recorded in 14 DIV cortical cultures treated with either vehicle (Ctrl) or 10 µg/ml 
GO for 14 days. (b-c) Percentages of spontaneously active cells (b) and mean resting Ca2+ 
concentrations measured at the cell body level (c). (d) The frequency of Ca2+-oscillations under 
basal conditions or in the presence of bicuculline (20 µM) displayed lower values for GO-treated 
neurons. (e-g) The kinetic analysis of Ca2+ transients shows a faster recovery of Ca2+ levels (time 
to 50% decay, g) in GO-treated neurons compared to control neurons, in the absence of changes 
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in the rise time (f). Data are means ± SEM. *p<0.05, two-tailed Student's t-test; n = 30 cells per 
experimental condition, from 4 independent neuronal preparations. 
 
Exposure to GO but not GR induces an imbalance between excitatory and 
inhibitory synaptic transmission 
The interactions of GR/GO nanosheets with the plasma membrane, together with the low 
degree of flake endocytosis observed upon graphene exposure, can potentially impact on the 
formation, maintenance and function of synaptic connections. Synapses are in fact the sites in 
which the highest intensity of membrane trafficking, membrane fusion/fission events and signal 
transduction cascades occur in the nervous tissue.35 Thus, we investigated whether the changes 
observed after treatment with GO were associated with alterations in the density of excitatory 
and inhibitory synapses and in the frequency and amplitude of miniature excitatory (mEPSCs) 
and inhibitory (mIPSCs) postsynaptic currents. 
In GO-treated neuronal networks the frequency of mEPSCs was strongly depressed 
(approximately 75% decrease) as compared to untreated or vehicle-treated neurons (Figure 5a, 
b). Moreover, the mEPSC amplitude was also significantly decreased by approximately 50% 
(Figure 5a, c) in the absence of effects on the current rise time and decay (Figure 5d). 
Strikingly, an opposite effect was found on mIPSCs, whose frequency was significantly 
increased in comparison with control samples (Figure 5e, f), in the absence of changes in the 
amplitude (Figure 5e, g) and in the current rise time and decay (Figure 5g). Interestingly, 
these effects on excitatory and inhibitory transmission were virtually specific for GO and totally 
absent in neurons exposed to GR flakes (Figure S8). In addition, a long-term exposure to GO 
flakes was required to provoke the synaptic effects, since mature neurons exposed for 24 h to 
either GO or GR flakes did not display any synaptic phenotype (Figure S7e-h). 
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Figure 5. Activity of excitatory and inhibitory synapses in primary cortical 
neurons treated with GO for 14 days. (a) Representative recordings of miniature 
excitatory postsynaptic currents (mEPSCs) in cortical neurons treated with GO (10 µg/mL) or 
vehicle. (b) Cumulative distribution of inter-event intervals and mean (± SEM) frequency of 
mEPSCs in control and GO-treated neurons. (c) Cumulative distribution and mean (± SEM) of 
mEPSC amplitude in control and GO-treated neurons. (d) Mean (± SEM) values of the rise and 
decay times of mEPSCs (one-way ANOVA and Bonferroni's multiple comparison test; 
***p<0.001; n = 15 cells from 2 independent neuronal preparations). (e) Representative 
recordings of miniature inhibitory postsynaptic currents (mIPSCs) in cortical neurons treated 
with GO (10 µg/mL) or vehicle. (f) Cumulative distribution of inter-event intervals and mean (± 
SEM) frequency of mIPSCs in control and GO-treated neurons. (g) Cumulative distribution and 
mean (± SEM) of mIPSC amplitude in control and GO-treated neurons. (h) Mean (± SEM) 
values of the rise and decay times of mIPSCs (one-way ANOVA and Bonferroni's multiple 
comparison test; *p<0.05; n = 10 cells from 2 independent neuronal preparations). 
While the amplitude of miniature currents depends on the quantal size (i.e., the number of 
neurotransmitter molecules released by each synaptic vesicle) and on the number and sensitivity 
of postsynaptic receptors responsible for the current generation, the frequency of miniature 
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currents depends on the spontaneous release probability (that is sensitive to the resting Ca2+ 
levels) and on the number of synaptic contacts impinging on the patched neuron. To elucidate the 
latter point, we double-stained cortical cultures with antibodies for β-III tubulin to identify 
neuronal processes and either the vesicular glutamate transporter VGLUT1 or the vesicular 
GABA transporter VGAT to visualize synaptic contacts (Figure 6).36-38 Indeed, treatment with 
GO induced a significant decrease in the density of excitatory glutamatergic contacts (Figure 
6c), while the density of inhibitory GABAergic synapses was fully preserved (even with a slight 
trend toward an increase; Figure 6d). The impaired excitatory/inhibitory synapse ratio and the 
imbalance between excitatory and inhibitory transmission observed in GO-treated neurons is in 
line with the reduced network activity of excitatory neurons observed by live Ca2+ imaging. 
 
 
 
 
 
Figure 6. Synaptic density in primary cortical neurons treated with GO for 14 
days. (a, b) Representative images of primary cortical neurons at 17 DIV triple stained for β-III 
tubulin (grey), VGLUT1 (green) and VGAT (red) are shown. Nuclei were stained with DAPI. 
(c, d) Density of VGLUT1-positive excitatory synapses (c) and of VGAT-positive inhibitory 
synapses (d) in untreated, vehicle-treated (Ctrl) and GO-treated neurons (scale bars 5 µm; one-
way ANOVA and Bonferroni's multiple comparison test; *p<0.05; **p<0.01; n=30 cells per 
experimental condition, from 3 independent neuronal preparations). 
 
Exposure to GO alters the lipid and protein content of primary cortical neurons 
The extensive Ca2+ imaging and synaptic transmission analysis revealed dramatic changes in 
Ca2+ homeostasis, in conjunction with a compromised synaptic transmission upon GO exposure. 
To specifically investigate the effect of this specific type of graphene and get a more 
comprehensive understanding of the intracellular pathways that are affected by GO, 
metabolomics and proteomics studies were carried out on two independent preparations of 
primary neurons chronically treated with GO. 
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An untargeted high-resolution LC-MS/MS lipidomic approach allowed us to observe 
substantial changes in the lipid composition of neurons treated with GO flakes compared to 
vehicle-treated cells, including both membrane and intracellular lipids. We first used an 
unsupervised Principal Component Analysis39 (Figure 7a) to generate a general overview of the 
changes induced by exposure of neurons to GO with respect to vehicle-treated neurons and GO 
alone (in cell culture medium). The plot describing the observed differences between the 
experimental groups shows a non-overlapping distribution of the three experimental groups with 
very limited dispersion. Using a Discriminant Analysis39, we identified a series of 
phosphatidylethanolamines (PEs), which are among the major cell membrane components, that 
were markedly upregulated in the GO group (Figure 7b). Other phospholipids, such as 
phosphatidylinositols (PIs) and phosphatidylserines (PSs) were also differentially regulated by 
the exposure to GO (Figure S9a). Interestingly, a dramatic up-regulation of the major vitamin 
D3 metabolite calcitriol was also observed. These appear to be striking alterations, especially 
when compared to other very abundant structural lipid species, such as cholesterol, which did not 
vary amongst samples (Figure 7b). Although the total cholesterol was not affected by GO, this 
lipid is known to redistribute in the cell membrane in response to a variety of stimuli 40-42 
However, when neurons were incubated with the cholesterol-specific fluorescent marker filipin, 
no detectable changes in membrane cholesterol distribution were observed between GO-treated 
and untreated cells (Figure S9d). 
We next performed proteomics on the same sample sets by digesting neuronal proteins and 
labeling the GO and vehicle-treated groups with TMT isobaric tags.43 As summarized in Figure 
7c, roughly 650 proteins were unambiguously identified in the two biological replicates, and 
more than 70% of them gave useful over/under expression data. Following data filtering,44 a final 
list of 405 proteins was used for expression analysis (Figure 7d and Supporting Information 
Excel file). From this dataset, 16 and 57 proteins showed respectively a marked (>20% in 
module) up-regulation and down-regulation in the GO group and were subjected to gene 
ontology. Quite interestingly, calmodulin (Calm1) and its closest functional interactors such as 
Ca2+/calmodulin-dependent kinase type II (CaMKII or Camk2d) and the catalytic subunit of the 
protein phosphatase 2B aka calcineurin (Ppp3c) and related proteins (such as γ-actin, Actg2) 
(Figure 7e) were amongst the major downregulated proteins, while a number of proteins 
involved in membrane trafficking and autophagy were substantially upregulated (Tables S2 
and S3). 
To validate these findings with an independent assay, we verified the up/down regulation of 
some proteins of interest by either qRT-PCR or western blot analysis (Figure 7f-g). Our data 
confirmed a statistically significant downregulation of a number of proteins involved in 
intracellular Ca2+-dependent activities including calmodulin (Calm1), CaMKII and calretinin 
(Calr) and of one mitochondrial import receptor (Tom70), as well as the upregulation of proteins 
controlling intracellular trafficking (T-complex protein 1 subunit delta, TCPD; ADP-ribosylation 
factor 4, Arf4; Nck-associated protein 1, NCKP1/Nap125) and autophagy (microtubule-
associated proteins 1A/1B light chain 3A, MLP3A/LC3). Notably, in the case of LC3, the active 
PE conjugated form (LC3II) was significantly upregulated, while its inactive precursor LC3I 
resulted downregulated. 
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Figure 7. Lipidomic and proteomic studies on primary neurons exposed to GO 
for 14 days. (a) Principal component analysis39 of the untargeted lipidomic experiment: dots 
representing individual neuronal samples cluster into the three experimental groups, indicating 
clear changes in lipid content induced by exposure to GO. Blue dots are reference samples, 
consisting of GO flakes in cell culture medium in the absence of cells. (b) 
Phosphatidylethanolamines (PEs) and calcitriol show a marked upregulation following exposure 
to GO, especially when compared to other invariant cell lipids, such as free cholesterol 
(***p<0.001 two-tailed Student's t-test). The analyte peak areas were used for quantification. 
These lipids are the major net contributors to the GO vs vehicle differences observed in (a). 
Values on the Y-axis are means (± SEM) normalized peak areas. (c) Results of the untargeted 
proteomics experiment: among the total positive protein hits, the two independent biological 
replicates gave ~70% of useful expression information that resulted in 405 quantified proteins. 
(d) Expression plot of the 405 protein hits: 16 proteins were overexpressed in GO by more than 
20%, while 57 were downregulated by more than 20%. (e) Rat calmodulin (Calm1) network of 
functional interactors. The proteins reported in italic red were represented in the untargeted 
dataset as markedly downregulated in neurons exposed to GO (-10 to -30% in both replicates, 
values for each protein are reported in the red squares), clearly indicating a significant 
downregulation of the whole pathway. (f) Calm1, Tomm70, Tcpd and Arf4 mRNA levels were 
quantified by qRT-PCR in neurons treated with either vehicle (Ctrl) or GO. GUSB and HPRT1 
were used as control housekeeping genes. (*p<0.05, **p<0.01, two-tailed Student's t-test; n = 3). 
(g) Western blot analysis of CaMKII, calreticulin (CLT), NCKP1/Nap125 (Nap125) and 
MLP3A/LC3 I/II in neurons following exposure to GO flakes. Calnexin was used as loading 
control. A representative experiment (left panel) and quantification (right panel; means ± SEM) 
are shown (*p< 0.05, **p< 0.01, two-tailed Student's t-test; n = 3). 
 
Given the expression changes in Ca2+-binding proteins, Ca2+ buffers and Ca2+-dependent 
enzymes, and the opposite effects observed in excitatory and inhibitory transmission, we 
investigated the expression levels of Ca2+ buffer proteins that are specific for inhibitory neurons, 
namely parvalbumin (PV), calbindinD28k (CB) and calretinin (CR) by quantitative western blotting 
of primary neurons exposed for 14 days to either GO or vehicle. Interestingly, all three 
interneuron-specific Ca2+ buffers were significantly downregulated, with a dramatic effect (4-fold 
reduction) for PV that is the specific Ca2+ buffer of fast-spiking interneurons (Figure S10). 
Altogether, these data confirm the presence of a dysregulation of Ca2+ homeostasis induced by 
treatment with GO that differentially affects excitatory and inhibitory neurons. 
 
Exposure to GO triggers macroautophagy in primary cortical neurons 
As post-mitotic cells, neurons are much more sensitive to accumulation of toxic components than 
replicating cells. Autophagy, macroautophagy in particular, is the only cellular degradation 
mechanism capable of eliminating large material aggregates, as well as expired, engulfed or 
damaged organelles. In the autophagic pathway, cytosolic components are sequestered in 
autophagosomes and degraded upon fusion with lysosomal components.45, 46 A tight control for 
degradation of cytoplasmic components by the autophagy is fundamental for neuronal survival 
and activity under physiological conditions and inhibition of autophagy is known to cause 
neurodegeneration in mature neurons.47 
An indication that chronic GO exposure could stimulate the autophagy pathway in primary 
neurons came from the proteomic screen that identified, among the most upregulated proteins, 
MLP3A/LC3, the mammalian orthologue of ATG8, which is mechanistically involved in the 
formation of autophagosomal vacuoles. LC3I is generated by proteolytic cleavage of pro-LC 
and, upon conjugation with PE, is converted into the active LC3II form that stimulates the 
formation of autophagosomes by specifically associating with their membranes.46 Western blot 
analysis further demonstrated a specific increase in LC3II at the expense of LC3I, consistent 
with an activation of the autophagic pathway in neurons chronically exposed to GO (Figure 8a; 
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see also Figure 7g). Interestingly, activation of LC3 involves PE that was also markedly 
upregulated by GO exposure (Figure 7b). The marked GO-induced activation of the autophagic 
pathway was confirmed by electron and confocal microscopy analysis (Figure 8b-d). The 
number of LC3-positive vesicles in GO-treated neurons exhibited a 2-3 fold increase with 
respect to untreated or vehicle-treated cells and the total area covered by autophagic vesicles, 
quantified at CLSM level, was dramatically increased (Figure 8e, f). 
 
 
Figure 8. Chronic exposure to GO stimulates autophagy in neurons. (a) 
Quantification of Western blot analysis of MLP3A/LC3 I/II in neurons following exposure to 
GO flakes (means ± SEM) are shown (**p<0.01, two-tailed Student's t-test; n=3). Calnexin was 
used as loading control. A representative experiment is shown in Figure 7g. (b) Autophagy 
reaction upon GO exposure was also confirmed by TEM analysis (black arrowheads). (c, d) 
Fluorescent confocal images of neuronal cells exposed to GO flakes or vehicle for 14 days, 
showing nuclei in blue (DAPI), β-III tubulin staining in green and LC3-positive vesicles in red 
(scale bar, 20 µm; 10 µm in zoomed images). (e, f) The number of LC3-positive vesicles as well 
as the dimension of LC3 bodies after GO exposure compared to untreated (N.T.) or vehicle-
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treated control (Ctrl) samples was quantified and found to be significantly higher in GO-treated 
neuronal cells (n=30 cells from 2 independent preparations; *p<0.05, one-way ANOVA and 
Bonferroni's multiple comparison test). 
 
DISCUSSION 
In this study, we investigated the effects of the environmental exposure of primary cortical 
neurons to GR and GO flakes. Our analysis started from standard biocompatibility and cell 
morphology tests, to include a detailed characterization of neuronal functionality and flake 
intracellular trafficking. Moreover, proteomic and lipidomic studies allowed us to explore, with 
unprecedented precision, the interactions of graphene with the protein and lipid machinery of the 
neurons. Our aim was to achieve a comprehensive understanding of the mechanisms underlying 
graphene-neuron interactions, thus laying the basis for the engineering of fully biocompatible 
biomedical devices where graphene will directly be interfaced with neuronal cells. 
One fundamental finding is that the interaction of neurons with GR/GO flakes does not affect 
neuronal cell viability. Neurons exposed to flakes are still able to grow and form a neuronal 
network after up to two weeks of GR/GO incubation with no significant changes in cell death or 
viability. Furthermore, also the passive and active electrophysiological properties, as well as the 
intrinsic excitability of neurons, were fully preserved upon both chronic and acute exposure to 
either GR or GO flakes, demonstrating that graphene-exposed cultures are substantially healthy. 
These results are in agreement with the observation that healthy neurons can be grown on planar 
graphene surfaces.18 
One topic of particular interest was the physical interactions of GR/GO flakes with the 
neuronal membrane, which is strongly dependent on the active surface and edges of the 
material.21, 28 Graphene flakes adsorbed onto the cell surface without apparently modifying or 
damaging the neuronal morphology. Large flake aggregates (in the µm-size order) mostly 
adhered to the cell membrane, while nanosheets were actively taken up and internalized by 
neurons. It was possible to track the trafficking of intracellular nanosheets from the early contact 
with the cell membrane to their final destination: graphene flakes that underwent endocytosis 
preferentially followed the endo-lysosomal pathway, with a significant percentage of them 
ending up into lysosomes after two-week incubation, in accordance with previous reports.24 
Notably GO nanosheets were more intensely endocytosed by neurons, consistent with the GO-
specific changes observed by physiological, lipidomic and proteomic analyses. Although the 
intracellular fate of graphene flakes is important, the majority of the GR/GO flakes were not able 
to enter neuronal cells, presumably because of the large aggregates they formed in solution and 
of the relatively low ability of neurons to perform bulk endocytosis. In addition, while membrane 
invaginations suggestive of active uptake mechanisms were frequently observed, rare events of 
flakes piercing through the membrane were also noticed. The final amount of graphene that co-
localized with the lysosomal marker LAMP1 was never higher than 50%, and moreover, free 
graphene flakes were constantly observed in the cytoplasm, leaving open the question on their 
final intracellular fate. Further investigations are needed to better understand the kinetics and 
molecular mechanisms used by graphene to enter neurons and the intracellular pathways 
followed by the material depending on the different sizes and surface chemistry of the graphene 
particles.  
However, when the physiological analysis was extended to the study of network activity, 
intraneuronal Ca2+ dynamics and synaptic communication, we found a clear distinct behavior of 
GR and GO flakes. While short- and long-term exposure to GR flakes was totally harmless for 
neurons and devoid of any effect on the analyzed parameters, long-term (but not short-term) 
contact with GO flakes had complex effects on network physiology, including: (i) overall 
depression of intracellular Ca2+ dynamics, with lower resting levels, and marked inhibition of 
network activity as shown by the lower frequency of spontaneous and evoked Ca2+ waves; (ii) 
downregulation of excitatory synaptic transmission with marked decreases in frequency and 
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amplitude of spontaneous synaptic currents and in the density of synaptic connections; (iii) 
upregulation of inhibitory synapses with an increased frequency of spontaneous synaptic currents 
and a fully preserved complement of inhibitory synapses. The resulting imbalance between 
synaptic excitation and inhibition causes the depression of the network electrical activity 
detected by Ca2+ imaging, an analysis that predominantly applies to excitatory neurons, which 
predominate under our culture conditions (≈ 80%).33 These effects are particularly relevant since 
GO represents the most promising graphene type for biomedical applications, because of its 
surface chemistry that allows high reactivity towards the biological matter and facilitates its 
functionalization by material chemistry.16, 48, 49 The selective effects of GO over GR can be 
explained by the different chemical reactivity of the two substances, directly related to the 
presence of oxygen species on the surface of GO flakes, which determines their surface charge 
and protein binding capability, although additional effects of roughness and morphology cannot 
be excluded. 
The functional effects of GO flakes only manifest after a long-term exposure and therefore 
they may result from complex neuronal responses involving transcription- and activity-
dependent structural changes in neuronal networks. Indeed, a lipidomic scan revealed 
upregulation of PEs and downregulation of PSs. PE constitutes about 30-36% of total 
phospholipid content of the plasma membrane and synaptic vesicle (SV) membranes50-52 and plays 
important roles in SV fusion/fission by modulating membrane curvature, synaptotagmin 
recruitment and formation of the SNARE fusion core complex.53 On the other hand, PS 
contributes to the negative charge of the cytosolic leaflets of the membranes that regulates the 
fusion propensity of the plasma membrane. While the upregulation of PE could be the expression 
of the intense membrane trafficking and activation of the endocytic/autophagic pathways 
stimulated by GO, the change in the PE/PS ratio may participate in the altered SV fusion and 
synaptic transmission. Lipidomic analysis also emphasized a dramatic increase in the production 
of calcitriol/vitamin D, a neurosteroid affecting the developing and adult brain54 and operating as 
a neuroprotective agent through a modulation of Ca2+ metabolism and Ca2+ entry through L-type 
Ca2+ channels.55 Such a dramatic upregulation of calcitriol/vitamin D is fully consistent with the 
depression of intracellular Ca2+ dynamics, observed after GO exposure and particularly for the 
lower resting levels and accelerated decay of action potential-triggered Ca2+ oscillations 
mentioned above. Consistent with these findings, the proteomic scan uncovered a strong 
downregulation of a series of proteins involved in Ca2+-dependent signal transduction (CaM, 
CaMKII, calcineurin). Since these proteins are preferentially or exclusively (CaMKII) expressed 
in excitatory neurons, these changes can significantly contribute to the depression of network 
activity and downregulation Ca2+ homeostasis brought about by chronic GO exposure. 
Interestingly, the three major interneuron-specific Ca2+ buffers (PV, CB and CR) specifically 
expressed by inhibitory cortical neurons56-58 are also markedly downregulated by GO exposure, 
suggesting the existence of an impaired buffering of cytosolic Ca2+ in inhibitory neurons that can 
in turn facilitate inhibitory transmission. 
How can the various findings be linked in a unifying pathogenic mechanism activated by GO? 
Chronic exposure to GO results in an imbalance between excitatory and inhibitory synaptic 
transmission with weakening of the former and strengthening of the latter. One possibility to 
explain the differential effect of GO nanosheets at excitatory and inhibitory synapses is that 
excitatory synapses are more vulnerable because of a higher permeability to GO flakes that can 
penetrate the synaptic cleft and jeopardize the exo-endocytotic cycle of SVs. However, this does 
not seem likely, since both excitatory and inhibitory synapses have a similar cleft thickness.59 A 
more attractive possibility is based on the functional and phenotypic differences between 
excitatory and inhibitory neurons that can be differentially targeted by GO. 
The strong impairment of excitatory transmission is characterized by a decreased frequency 
and amplitude of spontaneous synaptic currents and a sharp decrease in the density of excitatory 
synapses. The decreased mEPSC frequency parallels the reduction in synaptic density, although 
a decreased probability of spontaneous fusion by the decreased resting Ca2+ levels can also be 
involved. The reduction in mEPSC amplitude also implies a concomitant decrease/internalization 
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of postsynaptic AMPA-type glutamate receptors, a possible consequence of the intense endocytic 
processes initiated by contact with the GO flakes. This pre/post-synaptic depression of excitatory 
synaptic transmission could impact on the formation/maintenance of synaptic contacts, leading to 
adaptive pruning and reduction of the density of excitatory synapses. However, a direct effect of 
GO on the formation of synaptic contacts cannot be ruled out, since actin and Ca2+-mediated 
processes play an important role during synaptogenesis and both of them resulted depressed by 
GO exposure. On the other hand, inhibitory transmission is structurally preserved and 
functionally enhanced by GO exposure, with an increase of mIPSCs frequency without changes 
in current amplitude or synapse density. Inhibitory neurons may not be affected by vitamin D 
overexpression and Ca2+ downregulation. Rather, the marked downregulation of three major Ca2+ 
buffers specific for inhibitory neurons, known to shape their functional properties, indicate that 
the increased mIPSC frequency can be ascribed to an impaired buffering of cytosolic Ca2+ that 
increases the probability of spontaneous fusion. A schematic model summarizing our 
interpretation of the data is reported in Figure 9. 
We envisage a stream of events that begin with alteration of lipids and Ca2+-related proteins, 
which in turn affect synaptic activity resulting in an overall depressing effect on network 
activity. This can be initially triggered by the dysregulation of Ca2+ homeostasis and by the 
intense endocytic processes initiated by contact of the plasma membrane with the GO flakes. 
Importantly, the observed effects are likely a combination of the cellular changes induced by 
internalized flakes and of the membrane modifications induced by the extracellular aggregates 
that are in physical contact with the plasma membrane. In this respect, the strong upregulation 
and activation of the autophagosome-related protein LC3, associated with a clear induction of 
autophagy upon GO exposure (that was recently observed in non-neuronal cells)60, 61, suggest that 
neuronal networks exposed to GO tend to limit the potential damage by turning down electrical 
activity and activating autophagy as a stress response to the contact with graphene nanosheets.  
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 Figure 9. Schematic representation of the mechanisms of the effects of chronic 
exposure of GO on the activity of neuronal networks. Excitatory neurons display 
downregulated resting Ca2+ levels, decreased spontaneous firing (decreased frequency of Ca2+ 
transients) and decreased frequency and amplitude of spontaneous postsynaptic currents, 
associated with a decreased density of synaptic connections. These effects may result from 
calcitriol overexpression, lipidomic changes in synaptic phospholipids, increased endocytosis of 
postsynaptic receptors and strengthened inhibition by interneurons. On the contrary, inhibitory 
neurons exhibit an increased frequency of spontaneous postsynaptic currents, likely attributable 
to the downregulation of interneuron-specific Ca2+-buffers, and a preserved density of synaptic 
connections. The resulting imbalance between excitatory and inhibitory transmission overall 
decreases network excitability, activity and plasticity. 
 
 
CONCLUSIONS 
This work is, to our knowledge, the first to perform a comprehensive analysis of the effects of 
graphene flake exposure to primary neuronal cells, under controlled experimental conditions. 
Going beyond the mere analysis of cell viability, which has been indeed reported by several 
other groups,8, 10, 15, 62 we have conducted a detailed characterization of (i) the intracellular route of 
internalized flakes; (ii) the effects on synaptic functionality and neuronal excitability; and (iii) 
the changes induced by flake exposure onto the lipid and protein machineries of the neurons. 
Although graphene flake exposure does not impact on cell viability and network formation, it 
does nevertheless have important effects on neuronal transmission and network functionality, 
thus warranting caution when planning to employ this material for neurobiological applications. 
In this respect GO, which we demonstrated to be the most biologically reactive form, is also the 
 23 
most largely employed graphene derivative for technological and industrial applications. It is 
also important to point out that although the formation of aggregates affects only to a limited 
extent cell survival in vitro, it may have a much higher impact in living organisms, causing tissue 
damage and/or inflammation reactions.63, 64 This issue, together with our findings on the complex 
activity changes induced by chronic exposure to GO, will be crucial when attempting to design 
and engineer graphene-based devices for biomedical applications. 
While the present paper was under revision, a similar paper confirming the impairment of 
excitatory transmission by GO was published.65 
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METHODS 
Synthesis and characterization of pristine graphene and graphene oxide 
Pristine graphene (GR) flakes were prepared by exfoliation of graphite through interaction 
with melamine by ball-milling treatment.19 After exfoliation, melamine could be easily removed 
by filtration to obtain stable dispersions of few-layer graphene. In details, GR flakes were 
obtained by a methodology that uses mechanochemical activation by ball-milling to exfoliate 
graphite, through interactions with melamine (2,4,6-triamine-1,3,5-triazine) in solvent-free 
conditions. In a typical experiment, 7.5 mg of graphite (purchased from Bay Carbon, Inc. SP-1 
graphite powder) and 0.16 mMol of melamine were ball-milled in a Retch PM100 Planetary Mill 
at 100 rpm for 30 min in air atmosphere. The resulting solid mixtures were dispersed in 20 ml of 
water to produce stable black suspensions, which were subsequently filtered and washed in hot 
water to remove melamine. GR/H2O dispersions were obtained at a final concentration of 0.09 
mg/ml in Milli-Q-water. Melamine traces in the dispersions were estimated by Elemental 
Analysis (CHNS-932, Model NO: 601-800-500; LECO Corp., Saint Joseph, MI) to be 0.09 ppm. 
Graphene oxide (GO) was provided by Grupo Antolin Ingeniería (Burgos, Spain) by oxidation of 
carbon fibres (GANF Helical-Ribbon Carbon Nanofibres, GANF®) and sodium nitrate in sulfuric 
acid at 0 °C. While maintaining vigorous agitation, potassium permanganate was added to the 
suspension. After 30 min, water was slowly stirred into the paste. Then, the suspension was 
filtered and extensively rinsed with water to remove the presence of acids. For TEM analyses, 
water dispersions were placed on a copper grid (3.00 mm, 200 mesh, coated with carbon film). 
Samples were analyzed by High-Resolution TEM (HRTEM) using a JOEL 2100 electron 
microscope (JEOL, Peabody, MA). Lateral dimension distribution was calculated by using Fiji-
win32. UV-vis-NIR absorbance was performed from 2.4 to 14.2 µg/ml (GR samples) or 7.5 to 20 
µg/ml (GO samples) using 1 cm quartz cuvettes on a Cary 5000 UV-vis-NIR spectrophotometer 
(Agilent Technologies, Santa Clara, CA). For Raman spectroscopy, water dispersions were drop-
cast onto a silicon surface (CZ silicon wafers; Si-Mat Silicon Materials, Kaufering, Germany). 
Measurements were carried out using a 100x objective at 532 nm laser excitation using a 
SENTERRA Raman Microscope (Bruker, Billerica, MA). An average of ID/IG ratio was measured 
from different locations in the sample. The thermogravimetric analyses were performed with a 
TGA Q50 (TA Instruments, New Castle, DE) at 10 ºC/min in a nitrogen atmosphere. 
 
Preparation of primary neurons 
All experiments were carried out in accordance with the guidelines established by the 
European Community Council (Directive 2010/63/EU of 22 September 2010) and were 
approved by the Italian Ministry of Health. Primary cortical cultures were prepared from wild-
type Sprague-Dawley rats (Charles River, Calco, Italy). All efforts were made to minimize 
suffering and to reduce the number of animals used. Rats were sacrificed by CO2 inhalation, and 
18-day embryos (E18) were removed immediately by cesarean section. Briefly, enzymatically 
dissociated cortical neurons66 were plated on poly-D-lysine-coated (0.1 mg/ml) glass coverslips 
(Thermo-Fischer Scientific, Waltham, MA) at a density of 40.000 cells/ml. Cultures were 
incubated at 37 °C, 5% CO2, 90% humidity in medium consisting of Neurobasal (Gibco/Thermo-
Fischer Scientific) supplemented to reach final concentration of 5% glutamine, 5% 
penicillin/streptomycin and 10% B27 supplement (Gibco/Thermo-Fischer Scientific). All 
chemicals were purchased from Life Technologies/Thermo-Fischer Scientific unless stated 
otherwise. For experiments involving chronic treatments, cultures were incubated at 3 days in 
vitro (DIV) with a medium containing either 1 or 10 µg/ml of either GR or GO flakes. Controls 
were subjected to the same medium change with the addition of equivalent volumes of the 
respective vehicle (0.09 ppm melamine / H2O for GR flakes, H2O for GO flakes). Cultures were 
used at DIV 4, 6 and 17 (after 1, 3 and 14 days of GR / GO incubation, respectively). 
 
Cell viability assay 
Primary rat cortical neurons were exposed to GR and GO (1 and 10 µg/ml), or to equivalent 
volumes of the respective vehicle (see above) for 24 h, 96 h and 14 days. Cells were stained with 
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propidium iodide (PI, 1 µM) for cell death quantification, fluorescein diacetate (FDA, 2 µM) for 
cell viability and Hoechst 33342 (1 µM) for nuclei visualization for 3 min at room temperature 
(RT). Cell viability was quantified at 20x (0.5 NA) magnification using a Nikon Eclipse-80i 
upright epifluorescence microscope (Nikon, Tokio, Japan), with random sampling of 10 fields 
per sample (n = 3 coverslips/sample, from 3 independent culture preparations). Image analysis 
was performed using the ImageJ software and the Cell Counter plugin. 
 
Immunofluorescence staining 
Cortical neurons were fixed in phosphate-buffered saline (PBS) / 4% paraformaldehyde (PFA) 
for 20 min at RT. Cells were permeabilized with 1% Triton X-100 for 5 min, blocked with 2% 
fetal bovine serum (FBS) in PBS/Tween 80 0.05% for 30 min at RT and incubated with primary 
antibodies in the same buffer for 45 min. The primary antibodies used were: mouse monoclonal 
anti-β-tubulin III (#T2200, Sigma-Aldrich), mouse monoclonal anti-glial fibrillary acidic protein 
(GFAP, #G3893, Sigma-Aldrich), guinea pig polyclonal anti-vesicular glutamate transporter-1 
(VGLUT1, #AB5905, Millipore), rabbit polyclonal anti-vesicular GABA transporter (VGAT, 
#131003, Synaptic System) and rabbit polyclonal anti-microtubule-associated protein 1A/1B-
light chain 3 (LC3, #2775, Cell Signaling Technology). After the primary incubation and several 
PBS washes, neurons were incubated for 45 min with the secondary antibodies in blocking 
buffer solution. Fluorescently conjugated secondary antibodies were from Molecular Probes 
(Thermo-Fisher Scientific; Alexa Fluor 488 - #A11029, Alexa Fluor 568 - #A11036, Alexa Fluor 
647 – #A21450). Samples were mounted in ProLong Gold antifade reagent with DAPI 
(#P36935, Thermo-Fisher Scientific) on 1.5 mm-thick coverslips. 
For EEA1, LAMP1, VGLUT1/VGAT-positive terminals and LC3 vesicles, image acquisitions 
were performed using a confocal microscope (SP8, Leica Microsystems GmbH, Wetzlar, 
Germany) at 63x (1.4 NA) magnification. Z-stacks were acquired every 300 nm; 10 
fields/sample (n=2 coverslips/sample, from 3 independent culture preparations). Offline analysis 
was performed using the ImageJ software and the JACoP plugin for co-localization studies. For 
each set of experiments, all images were acquired using identical exposure settings. For VGLUT 
and VGAT experiments, values were normalized to the relative cell volume calculated on the 
basis of β-tubulin III labeling. 
 
Scanning and Transmission Electron Microscopy  
For SEM analysis, primary cortical neurons treated with GR/GO flakes (1 and 10 µg/ml) or 
with the respective vehicle for 1, 3 and 14 days were fixed with 1.5% glutaraldehyde in 66 mM 
sodium cacodylate buffer and post-fixed in 1% OsO4. Sample dehydration was performed by 5 
min washes in 30%, 50%, 70%, 80%, 90%, 96% and 100% EtOH solutions. In order to fully dry 
the samples, overnight incubation with 99% hexamethyldisilazane (HMDS) reagent (#440191, 
Sigma-Aldrich) was performed. Before SEM acquisition, coverslips were sputter-coated with a 
10 nm layer of 99% gold (Au) nanoparticles in an Ar-filled chamber (Cressington, Sputter 
Coater 208HR), and imaged using a JEOL JSM-6490LA scanning electron microscope. 
For TEM analysis, primary cortical neurons treated with GR / GO flakes (1 and 10 µg/ml) or 
with the respective vehicle for 1, 3 and 14 days were fixed with 1.2% glutaraldehyde in 66 mM 
sodium cacodylate buffer, post-fixed in 1% OsO4, 1.5% K4Fe(CN)6 0.1 M sodium cacodylate, en 
bloc stained with 1% uranyl acetate dehydrated and flat embedded in epoxy resin (Epon 812, 
TAAB). After baking for 48 h at 60 °C, the glass coverslip was removed from the Epon block by 
thermal shock using liquid N2. Neurons were identified by means of a stereomicroscope, excised 
from the block and mounted on a cured Epon block for sectioning using an EM UC6 
ultramicrotome (Leica Microsystem, Wetzlar, Germany). Ultrathin sections (70 nm thick) were 
collected on copper mesh grids and observed with a JEM-1011 electron microscope operating at 
100 kV and equipped with an ORIUS SC1000 CCD camera (Gatan Inc., Pleasanton, CA). For 
each experimental condition, at least 6 images were acquired at a magnification up to 10,000x. 
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Patch-clamp Electrophysiology  
Primary rat cortical neurons exposed to GR/GO flakes (1 and 10 µg/ml) or to the respective 
vehicle were used for patch-clamp recordings after either 24 h or 14 days. The experiments were 
performed using a Multiclamp 700B amplifier (Axon Instruments, Molecular Devices, 
Sunnyvale, CA, USA) and an upright BX51WI microscope (Olympus, Japan) equipped with 
Nomarski optics. Patch electrodes fabricated from thick borosilicate glasses were pulled to a 
final resistance of 4-6 MΩ. Recordings with either leak current >100 pA or series resistance >20 
MΩ were discarded. All recordings were acquired at 50 kHz. For the analysis of neuronal 
excitability, recordings in current-clamp configuration were performed in Tyrode extracellular 
solution in which D-(-)-2-amino-5-phosphonopentanoic acid (D-AP5; 50 µM), 6-cyano-7 
nitroquinoxaline-2,3-dione (CNQX; 10 µM), Bicuculline methiodide (30 µM) and (2S)-3-[[(1S)-
1-(3,4-Dichlorophenyl)ethyl] amino-2-hydroxypropyl] (phenylmethyl)phosphinic acid 
hydrochloride (CGP; 5 µM) were added to block NMDA, non-NMDA, GABAA and GABAB 
receptors, respectively. The internal solution (K-gluconate) was composed of (in mM): 126 K 
gluconate, 4 NaCl, 1 MgSO4, 0.02 CaCl2, 0.1 BAPTA, 15 Glucose, 5 Hepes, 3 ATP, 0.1 GTP, pH 
7.3. Current-clamp recordings were performed at a holding potential of -70 mV, and action 
potential firing was induced by injecting current steps of 25 pA lasting 500 ms. All parameters 
were analyzed using the pClamp (Molecular Devices) and Prism6 (GraphPad Software, Inc.) 
softwares. Spontaneous miniature excitatory postsynaptic currents (mEPSCs) and spontaneous 
miniature inhibitory postsynaptic currents (mIPSCs) were recorded in voltage-clamp 
configuration in the presence of tetrodotoxin (TTX, 300 nM) in the extracellular solution to 
block the generation and propagation of spontaneous action potentials. mPSCs were acquired at 
10- to 20-kHz sample frequency, filtered at half the acquisition rate with an 8-pole low-pass 
Bessel filter and analyzed by using the Minianalysis program (Synaptosoft, Leonia, NJ). The 
amplitude and frequency of mPSCs were calculated using a peak detector function using 
different appropriate threshold amplitude and area. 
 
Lipidomic and Proteomic Studies 
Solvents and chemicals were purchased from Sigma Aldrich (Milan, Italy). TMT duplex kits 
for peptide labeling were purchased from Thermo-Fisher Scientific. All the LC-MS instruments, 
columns and softwares used for metabolomics were from Waters Inc. (Milford, MA). MASCOT 
software for proteomics was purchased from MatrixScience Ltd. (London, UK). Pathway 
analysis on proteomics data was performed using publicly available REACTOME 
(www.reactome.org) and STRING (http://string-db.org/) software. Manual annotation of proteins 
for their biological functions was performed using the UNIPROT database 
(http://www.uniprot.org). 
 
Untargeted Lipidomics 
Sample preparations. Two independent preparations of primary cortical neurons were 
incubated for 2 weeks in either GO or vehicle. Eight technical replicates (0.5 million cells) per 
biological replicate were prepared. A reference incubation of GO without cells was also prepared 
and analyzed as reference blank (Medium+GO). At the end of the experiment, neurons were 
washed twice in serum-free medium then scraped in 0.5 ml mQ water, transferred in 2 ml tubes 
and immediately frozen in dry ice. Lipids were extracted by adding 1.3 ml of cold methanol 
(MeOH) to the samples and the tubes were vortexed for 10 min, then centrifuged for 10 min at 
7000 x g. The supernatant solutions were then collected and the precipitates were re-extracted 
with 0.2 ml of MeOH-MTBE (methyl-terbutyl ether) 1:1. Supernatants from the two extractions 
were pooled, transferred into clean glass vials, dried under nitrogen stream and stored at -80 °C 
until used. On the day of analysis, samples were re-dissolved in 0.1 ml of MeOH/CHCl3 solution 
(9:1) and transferred to glass vials for injection. Precipitates were kept and stored at -80 °C for 
proteomics analysis. 
Data acquisition. Untargeted LC-MS/MS analyses were carried out on a UPLC Acquity system 
coupled to a Synapt G2 QToF high-resolution mass spectrometer, operating in both positive 
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(ESI+) and negative (ESI-) ion modes. Lipids were fractionated on a reversed-phase C18 T3 
column (2.1x100 mm) kept at 55 °C at a flow rate of 0.4 ml/min. The following gradient 
conditions were used: eluent A was 10 mM ammonium formate in 60:40 acetonitrile/water, 
eluent B was 10 mM ammonium formate in 90: 10 isopropyl alcohol/acetonitrile; after 1 min at 
30%, solvent B was brought to 35% in 3 min, then to 50% in 1 min, and then to 100% in 13 min, 
followed by a 1 min 100% B isocratic step and reconditioning to 30% B. Total run time was 22 
min. Injection volume was set at 4 ml. Capillary voltages were set at 3kV and 2kV for ESI+ and 
ESI-, respectively. Cone voltages were set at 30V for ESI+ and 35V for ESI-, respectively. 
Source temperature was 120 °C. Desolvation gas and cone gas (N2) flows were 800 l/h and 20 
l/h, respectively. Desolvation temperature was set to 400 °C. Data were acquired in MSe mode67 
with MS/MS fragmentation performed in the trap region. Low energy scans were acquired at 
fixed 4eV potential and high-energy scans were acquired with an energy ramp from 25 to 45eV. 
Scan rate was set to 0.3 s per spectrum. Scan range was set from 50 to 1200 m/z. Leucine 
enkephalin (2 ng/ml) was infused as lock mass for spectra recalibration. 
Data analysis. Raw data from high-resolution LC-MS/MS runs for either polarity (ESI+ or 
ESI-) were subjected to a Pareto-scaled, Principal Component Analysis (PCA)44 using the 
MarkerLynx software. Accurate masses (m/z) and retention time values (RT) were included in 
the multivariate analysis and assigned as X-variables (markers). The peak area for each putative 
marker was normalized by the total markers area and used for quantitative evaluation. Only 
markers observed in all the replicates were retained. Following this process, a clear group 
separation was observed for both polarities. The goodness of fit of the generated model was: R2= 
0.839, Q2=0.809 for Principal Component 1 and R2=0.911,Q2=0.888 for Principal Component 
1, clearly indicating an extremely reliable multivariate data model. The metabolic differences 
related to the exposure of neurons to GO were then investigated by comparing the Vehicle and 
the GO groups using an Orthogonal Project to Least Squares Discriminant Analysis model 
(OPLS-DA).68 From the corresponding S-plot, those metabolites that showed significant up- or 
down-regulation between the two groups were retained and the corresponding marker list, 
reporting all the detected (m/z, RT) pairs, was generated by the software. The markers list was 
then exported to an Excel datasheet for further calculations, following the protocol recently 
described by Gonzalez-Domínguez.69 Putative markers were then further screened by 2-tailed 
Student's t-test (Vehicle vs GO groups) and fold-change between the groups. A preliminary F-
test was performed to discriminate equal or unequal data variances between the groups (and thus 
performing a homoscedastic or heteroscedastic t-test). Only those metabolites showing a 
difference p-value lower than 0.05 between the groups were retained and manually verified to 
eliminate spurious peaks. Retained metabolites were then identified, starting from those showing 
the absolute highest fold-change between the two groups. The accurate mass list was searched 
against the METLIN70, 71 web-based algorithm, setting an m/z tolerance of 5 ppm and allowing [M-
H]-, [M+FA-H] - and [M-H2O-H] – for the negative ion mode and [M+H]+, [M+NH4]+, 
[M+Na]+, [M+K]+, and [M-H2O+H]+ for the positive ion mode as adducted species. Criteria for 
matching were as follows: accurate mass matching, class specific retention time and adduct type 
consistency, as reported by Cajka et al.72 and, whenever possible, accurate tandem mass data 
matching, following the indications on MS/MS fragmentation patterns already available in the 
literature.73-76 
 
Untargeted Proteomics 
Sample preparation. Protein precipitates resulting from the lipid extraction described above 
were used for quantitative proteomics experiments, using TMT diplex isobaric tags.77 Briefly, 
following BCA protein assay,78 80 μg aliquots of proteins were collected from all the replicates of 
GO and vehicle groups, resuspended in 100 mM ammonium bicarbonate, pH 8.0, reduced with 
100 mM dithiotreithol (2 ml, 60°C for 45 min), alkylated with 100 mM iodoacetamide (4 ml, 
room temperature for 1 h) and then digested O/N at 37 °C with proteomic-grade trypsin (1:50 in 
weight with the sample). Chemical labeling with TMT tags was then performed, assigning 
reporter 126 m/z to vehicle group and reporter 127 m/z to GO group. Labeled peptides were 
dried under nitrogen and resuspended in 100 ml of mobile phase A for proteomic analysis. 
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Data acquisition. Peptides were loaded on an Acquity UPLC BEH C18 (75 mm x 250 mm, 1.7 
µm) nanocolumn and separated using a linear gradient of B from 3 to 45% in 3 h, followed by 10 
min at 90% B and reconditioning to 3%. Flow rate was set to 350 nl/min. Total run time was 4 h. 
Injection volume was set at 5 µl. Eluting peptides were analyzed in positive ESI mode on a 
Synapt G2 QToF high-resolution mass spectrometer using a nanoLockspray ion source. The 
capillary voltages were set at 1.8 kV. The cone voltage was set at 27 V. The source temperature 
was set to 90 °C. Scan range was set from 50 to 1600 m/z. Leucine enkephalin (2 ng/ml) was 
infused as lock mass for spectra recalibration. Charge states 2+ to 4+ were selected for MS/MS 
analysis (maximum 4 precursors per MS survey scan) and dedicated collision energy profiles 
were automatically set by the acquisition software. 
Data analysis. Following peak recalibration and peak-list preparation, MS/MS spectra were 
searched by MASCOT against the SWISSPROT database (Rattus norvegicus as taxonomy). 
TMT2plex and cysteine carbamidomethylation were selected as fixed modifications. 
Acetylation, methionine oxidation, phosphorylation (STY), methylation and deamidation were 
selected as variable modifications. A minimum of 2 unique peptides per protein and a false 
discovery rate below 0.05 were set for positive protein identification. At least 3 unique peptides 
showing an individual p-value < 0.05 were used for protein over/under-expression evaluation. 
Following a careful data comparison step, consisting in a trend analysis of the two biological 
replicates and an evaluation of the absolute differences in the up/down regulation ratios between 
the two replicates, the following criteria were used to generate the final list of up/down-regulated 
proteins: 1) hits showing opposite regulation trends between the two replicates and an absolute 
difference higher than 20% were discarded; 2) hits showing opposite regulation trends between 
the two replicates and an absolute difference lower than 20% were retained; 3) the same 
regulation trends were retained for any delta. 
Pathway analysis and protein annotation. Pathway analysis on the top over (> +20%) and 
under (< -20%) expressed proteins was performed using the REACTOME software.79 The 
calmodulin pathway analysis was performed using STRING80 to visualize and investigate the 
closest functional interactors. Manual annotation of protein functions was done using the 
UNIPROT database.81 
 
RNA preparation and Real-time PCR analysis 
Total RNA was extracted with Trizol (Invitrogen, Carlsbad, CA) according to manufacturer’s 
instructions, purified using RNeasy MinElute Cleanup Kit (Qiagen, Hilden, Germany), and 
reverse transcribed into cDNA using the SuperScript III First-Strand Synthesis System 
(Invitrogen). Gene expression was measured by quantitative real-time PCR using CFX96 Touch 
Real-Time PCR Detection System (Biorad, Hercules, CA). Relative gene expression was 
determined using the 2-ΔΔCT method. Gusb and Hprt1 were used as control housekeeping genes. 
The list of primers used is provided in Table S4. 
 
Protein Extraction and Western Blotting Analysis 
Total protein lysates were obtained from cells lysed in RIPA buffer (10 mM Tris-HCl, 1 mM 
EDTA, 0.5 mM EGTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% sodium dodecyl 
sulfate, 140 mM NaCl) containing protease and phosphatase inhibitor cocktails (Roche, Monza, 
Italy). The soluble fraction was collected and protein concentration was determined using BCA 
Protein Assay Kit (Thermo-Fischer Scientific). For Western blotting, protein lysates were 
denatured at 99°C in 5X sample buffer (62.5 mM Tris-HCL, pH 6.8, 2% SDS, 25% glycerol, 
0.05% bromophenol blue, 5% β-mercaptoethanol, deionized water) and separated on SDS-
polyacrylamide gels (SDS-PAGE). The following antibodies were used: LC3 (0231, Nanotools, 
Teningen, Germany), parvalbumin (195 002, Synaptic System, Germany), calretinin (AB5054, 
Millipore, MA, USA), P125NAP1 (07-515; Merck, MA), calreticulin (2891, CST, Danvers, 
MA), CaMKII (MA1-048, Thermo-Fischer Scientific), calbindinD28k (300, Swant, Marly, 
Switzerland), calnexin (ADI-SPA 860, Enzo Life Science, Farmingdale, NY). Signal intensities 
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were quantified by ChemiDoc MP Imaging System (GE Healthcare BioSciences, 
Buckinghamshire, UK). 
 
Calcium Imaging 
Cultures were loaded for 30 min at 37 °C with 1 µg/ml cell-permeable Fura-2 AM (#F1221, 
ThermoFisher) in the culture medium. Cells were then washed in recording buffer (10 mM 
HEPES pH 7.4, 150 mM NaCl, 3 mM KCl, 1 mM MgCl2, 10 mM Glucose, 2 mM CaCl2) for 30 
min at 37 °C to allow hydrolysis of the esterified groups. Coverslips with cells were mounted on 
the imaging chamber and loaded with 0.5 ml recording buffer. Fura-2-loaded cultures were 
observed with an IX-81 motorized inverted epifluorescence microscope (Olympus, Tokyo, 
Japan) using a UplanSapo 60 x 1.35 NA oil-immersion objective (Olympus) and recordings were 
performed from visual fields containing 5 ± 2 neurons on average. During the analysis, we 
selected the cells by drawing regions of interest (ROI) around their bodies to reduce any 
background.82 Samples were excited at 340 and 380 nm by a MT20 Hg-Xe lamp (Olympus). 
Excitation light was separated from the emitted light using a 395 nm dichroic mirror. Images of 
fluorescence emission > 510 nm were acquired continuously for a maximum of 2400 s (200 ms 
individual exposure time) by using a Hamamatsu Orca-ER IEEE1394 CCD camera (Hamamatsu 
Photonics, Hamamatsu City, Japan). The camera operated on 2x2 pixel binning mode and the 
imaging system was controlled by an integrating imaging software package (Cell^R; Olympus). 
To induce rhythmic bursts, 20 µM bicuculline methiodide was applied after 5 min recording. Ca2+ 
concentration was calculated as in Grynkiewicz et al.: 83 Ca2+ = 𝐾𝑑 × 𝑅 − 𝑅𝑚𝑖𝑛𝑅𝑚𝑎𝑥 − 𝑅×𝐹380 𝑚𝑎𝑥𝐹380 𝑚𝑖𝑛  where R is the measured 340/380 nm ratio; Rmin and Rmax are the ratios in absence of Ca2+ or 
when Fura-2 is saturated by Ca2+, and was determined by incubating cells in 0 Ca2+ recording 
buffer with 5 mM EDTA or treating cells with 1 µM ionomycin in recording buffer containing 
increasing concentrat ion of Ca2+, ranging from 1 nM to 10 mM. F380max and F380min are the 
fluorescence intensity of 380 nm excitation at 0 Ca2+ and at Ca2+ saturation. The in situ calibration 
was performed by loading cells with Fura-2, then measuring the 340/380 nm ratios in Ca2+ buffer 
mixtures that covered the [Ca2+] range of interest. To obtain the calibration curve (Figure S11), 
the values were plotted and the X-intercept representing the log of the Kd in the Grynkiewicz 
equation was calculated by linear regression (-3,07). Recorded images were analyzed off-line by 
the Cell^R (Olympus, Tokio, Japan) and Prism6 softwares. 
 
 
Statistical Analysis 
Data were analyzed by paired/unpaired Student’s t-test or, in case of more than 2 experimental 
groups, by one-way analysis of variance (ANOVA) followed by the Bonferroni's post-hoc 
multiple comparison test using the Prism6 (GraphPad Software, Inc.) software. Significance 
level was preset to p<0.05. Data are expressed as means ± SEM throughout for number of cells 
(n). The normal distribution of experimental data was assessed using the Kolmogorov-Smirnov 
test. 
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